publication date: Jan. 17, 2014


Funding Opportunities

Howard Hughes Medical Institute

Seeks up to 25 New Researchers

The Howard Hughes Medical Institute is seeking to appoint up to 25 new biomedical researchers through a national open competition. The initiative represents an investment of approximately $150 million in basic biomedical research over the next five years.

The competition is open to basic researchers and physician scientists at more than 200 eligible institutions who study significant biological problems in all of the biomedical disciplines, including plant biology, as well as in adjacent fields such as evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology. Those selected in this competition will receive a five-year appointment to the institute, which is renewable pending scientific review.

“The flexibility that comes with HHMI support allows people to move into new scientific areas more easily,” said Erin O’Shea, vice president and chief scientific officer. “I can’t emphasize enough how difficult that kind of movement can be with traditional sources of funding.”

Applications must be received by June 3. Candidates apply directly to HHMI. Successful candidates are expected to meet the following criteria:

• Hold a PhD, and/or MD, or equivalent degree.

• Hold a tenured or tenure-track position as assistant professor or higher academic rank (or the equivalent) at an eligible U.S. institution. Federal government employees are not eligible.

• Have more than five but no more than 15 years of post-training, professional experience.

• Be the principal investigator on one (or more) active, national, peer-reviewed research grants with a duration of at least three years.

All … Continue reading 40-03 Funding Opportunities

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.